Genomic Test Spares 68% of Breast Cancer Patients from Chemo

A massive UK trial found that most high-risk breast cancer patients can safely skip chemotherapy based on a simple genomic test that already exists.

This breakthrough could transform treatment for millions while preserving quality of life.